Stay updated on Satralizumab in Generalized Myasthenia Gravis Clinical Trial

Sign up to get notified when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    External information links to MedlinePlus Genetics, DailyMed, PubMed, and NIH/NLM pages were removed from the Study Details page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-10-27T19:09:29.000Z thumbnail image
  3. Check
    34 days ago
    Change Detected
    Summary
    - Added a government-operations notice about potential delays and current status, plus links for updates. - Updated version to v3.2.0. - Removed the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-06T05:33:56.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Major update: page now shows Revision: v3.1.0 and removes several drug-safety topics; indicates a content reorganization rather than addition of new substantive material.
    Difference
    0.2%
    Check dated 2025-09-29T03:05:33.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.0.2 added; previous v3.0.1 removed, and the 'Back to Top' element was deleted.
    Difference
    0.1%
    Check dated 2025-09-14T19:02:45.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.1%
    Check dated 2025-09-07T15:04:38.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The webpage has been updated to include new facility names and locations, as well as a list of publications related to satralizumab and myasthenia gravis. Notably, several previous location entries have been removed, indicating a refinement in the information presented.
    Difference
    9%
    Check dated 2025-08-31T11:47:18.000Z thumbnail image

Stay in the know with updates to Satralizumab in Generalized Myasthenia Gravis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.